Our Research.

We discover personalized medical solutions for environmentally triggered diseases.

Our Research.

We discover personalized medical solutions for environmentally triggered diseases.

Translation: Where Medical Research Reaches People

How can we bring new scientific insights to patients more quickly? At Helmholtz Munich, we work hand in hand with leading…

Nurse and patient in hospital bed with medical monitors

How Foundation Models Are Shaping Biomedical Research

AI-powered foundation models like GPT have evolved from everyday tools for simple tasks to powerful systems capable of…

An AI powered system automating remote patient monitoring by analyzing real time health data and vital signs, futuristic AI-driven healthcare platform

Science Through an Artistic Lens

In a world where scientific innovation is increasingly interconnected, the RepliFate-Artist in Residence program seeks to…

Cellular Reprogramming Necklace by Anna Dumitriu photo credit Audrey Rose Mizzi large_QUER

Porträt Marcus Conrad
Hochformat
Background: HDC Indoor

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich was awarded the German Cancer Award 2026 in the category “Experimental Research”, together with Prof. José Pedro Friedmann Angeli of the University of…

Doctor drawing man's blood sample in clinic, closeup AdobeStock_1937412501

A population-based cohort study provides new data on the prevalence of early-stage type 1 diabetes in young adults, addressing a gap in epidemiological research. Using samples from the LISA and GINIplus cohorts and methodologies established in the…

Nanotechnology in Cholesterol Research AdobeStock_822311587

A team at Helmholtz Munich and the Technical University of Munich (TUM) has developed a new microscopy technique that can distinguish lipid species in living cells – in particular cholesterol and sphingomyelin – and map them without the need for…

Helmholtz Munich Expert Hour at German Bundestag

How can scientific breakthroughs reach the people more quickly? This question was the focus of the Helmholtz Munich Expert Hour on March 25 in the German Bundestag. Under the title “From Research to Patients – Translation and AI in Medicine”,…

12.07.2023, Neuherberg: Helmholtz Pioneer Campus Opening. Foto: Matthias Balk/Helmholtz Zentrum München

At its most recent plenary session, the Bavarian Academy of Sciences and Humanities (BAdW) elected 13 distinguished scholars as new members. Among them are three researchers from Helmholtz Munich: Prof. Maria-Elena Torres-Padilla, Prof. Fabian Theis,…

EDENT1FI (“European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception”), a research project led by Prof. Anette-Gabriele Ziegler from Helmholtz Munich and Prof. Chantal Mathieu from the KU Leuven, has reached an…

The American Diabetes Association (ADA) has announced the recipients of this year's National Scientific and Health Care Achievement Awards. Among this year’s awardees is Prof. Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at…

Biomedical engineering applies engineering principles to address challenges in medicine and biology. To explore ways of strengthening biomedical engineering as a driver of innovation and growth in Europe, EMBO and the Helmholtz Bioengineering…

In a joint guest article published in Table.Media, bioengineering expert Vasilis Ntziachristos and deep-tech specialist Francis de Véricourt examine the key levers needed to sustainably advance biomedical innovation in Germany and Europe. The two…

Fabian Theis bei Eröffnung des Google AI Centers Berlin

On March 5, Google opened its first German AI Center in Berlin. The event was attended by representatives from politics, business, and science, including Federal Research Minister Dorothee Bär, Federal Digital Minister Karsten Wildberger, Berlin's…

Helmholtz Munich and Novartis Biomedical Research are launching a four-year collaboration to advance kidney disease research. Starting in early 2026, the partnership will work to develop an integrated, cross-species “kidney disease atlas” at…

Helmholtz Munich has been awarded a prestigious grant of up to 900 000 US Dollar from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support the research into early-stage T1D in adults,…

Dr. Arcangela Iuso from the Institute of Neurogenomics at Helmholtz Munich was awarded the Eva Luise Köhler Research Award. The foundation thus honors a highly innovative research project on RNA base editing for a rare neurodegenerative disease.

The journal Metabolism honors Dr. Anja Schork, who works at the Institute for Diabetes Research and Metabolic Diseases at Helmholtz Munich at the University of Tübingen and at the German Center for Diabetes Research (DZD), with the Junior Faculty…

Photorespiration has long been regarded as an energetically costly side reaction of photosynthesis, reducing plants’ net carbon gain. Now, researchers at Helmholtz Munich, in collaboration with Heidelberg University and the Technical University of…

A recent study from the NAKO Health Study, involving researchers at Helmholtz Munich, shows that while a large proportion of the approximately 80,000 participants maintained stable mental health throughout the COVID-19 pandemic, symptoms of…

Prof. Sandra Hummel, lead scientist of the research area “Lifestyle, Obesity, and Epigenetic Programming in Type 1 and Gestational Diabetes” at the Institute of Diabetes Research at Helmholtz Munich, has been awarded the Dr. Heinz Bürger-Büsing…

Helmholtz Biomedical Engineering Initiative

The Helmholtz Association is launching a nationwide biomedical engineering initiative to accelerate technology development and transfer activities. Led by its established Health Centers, “Helmholtz Biomedical Engineering” brings together cutting-edge…

Helmholtz Munich coordinates a new €4.9 million Horizon Europe project that will support cities with science-based strategies to reduce pollution and protect public health.

corona virus 2019-ncov flu outbreak, covid-19 3d banner illustration, microscopic view of floating influenza virus cells

The German National Cohort (NAKO) contributes its scientific expertise to the National Decade of Post-Infectious Diseases initiated by the Federal Ministry of Research, Technology and Space (BMFTR). With two central projects, it makes an important…

Core facilities support and enable our center’s research by providing centralized access to cutting-edge technologies, instruments and highly skilled staff, fostering innovation and connecting scientists across disciplines.

Find out more

Artificial Intelligence in Healthcare - New AI Applications in Medicine

Our cutting-edge research forms the basis for medical innovations. Together with our partners, we are accelerating the transfer of our research to bring new ideas from the laboratories to application even faster.
n addition to implementing innovative diagnostics, medical technologies, sustainable prevention measures and personalized therapeutics, we are shaping a dialogical and interactive transfer of knowledge. In this way, we make a valuable contribution to a healthier society.

More information

Eleftheria Zeggini

"We discover breakthrough solutions for better health in a rapidly changing world."

to Eleftheria's page

Prof. Dr. Eleftheria Zeggini

Program Director ENABLE

Stephan Herzig

"It is my vision to successfully drive a mechanistic finding into clinical application in the area of obesity-related metabolic dysfunction as well as cancer cachexia."

to Stephan's page

Stephan Herzig, Helmholtz Diabetes Center, IDC, grüner Hintergrund, Tunger Portrait 2022

Prof. Dr. Stephan Herzig

Director of the Diabetes Center, Scientific Director

Martin Hrabě de Angelis

"Leading science means guiding discovery toward public good – with excellence, integrity, and impact."

to Martin's page

Porträt Martin Hrabe de Angelis
Querformat
Background: Office / Indoorplant

Prof. Dr. Dr. h.c. Martin Hrabě de Angelis

Member and Spokesperson of the Executive Board (acting), Director of the Institute of Experimental Genetics, Scientific Director

Fabian Theis

"With AI we can imagine a future where diagnosing and treating diseases is more affordable, widely available, and thus more democratic."

to Fabian's page

Prof. Dr. Fabian Theis

Director of the Computational Health Center

Vasilis Ntziachristos

"Our research at Helmholtz Munich is driven by our interest to provide solutions that address critical unmet medical need and positively impact healthcare and the well-being of society."

Prof. Dr. Vasilis Ntziachristos

Director of the Bioengineering Center

Erika von Mutius

"I am a passionate pediatrician scientist. My research focusses on the roots of asthma and allergy development with the aim of ultimately preventing these diseases in children at risk."

Prof. Dr. Erika von Mutius

Director of the Environmental Health Center

Magdalena Götz

"My vision is to explore the mechanisms of neurogenesis to use it for instructing neurogenesis for replacement of lost neurons."

Prof. Dr. Magdalena Götz

Director of the Stem Cell Center

Michael Sattler

"We combine integrative structural biology to elucidate molecular mechanisms of biological pathways, highlighting the essential roles of dynamics and transient regulatory interations to enable innovative structure-based drug discovery."

to Michael´s page

Prof. Dr. Michael Sattler

Director of the Molecular Targets & Therapeutics Center

We collaborate with a dynamic network of regional and international partners. Together, we engage in impactful projects and cooperations that shape the future of medicine.
Read more

Blue and white sphere network structure - abstract design connection design - 3D illustration

Our Research.

Our Research.

On This Page

Translation: Where Medical Research Reaches People

How Foundation Models Are Shaping Biomedical Research

Science Through an Artistic Lens

Marcus Conrad Receives German Cancer Award 2026

Rethinking Early Detection: Type 1 Diabetes in Young Adults

Lipid Identification: Chemical Fingerprint Instead of Dye

Helmholtz Munich Expert Hour: Bringing Research Effectively into Healthcare

Three Helmholtz Munich Researchers Elected to Bavarian Academy

100,000 Participants Screened for Early-Stage Type 1 Diabetes in the EDENT1FI Project

Timo Müller Receives the ADA 2026 Outstanding Scientific Achievement Award

Biomedical Engineering: Science Translation for Future Health

The High-Tech Agenda Needs a Catalytic Moment for Biomedical Innovation

Google Opens AI Center in Berlin and Supports AI Projects by Fabian Theis

Helmholtz Munich Launches Collaboration on AI-Driven Kidney Disease Research

Helmholtz Munich Secures Funding to Investigate Early-Stage Type 1 Diabetes in Adults

Arcangela Iuso Receives the Eva Luise Köhler Research Award

Anja Schork Receives “Junior Faculty Award 2025”

More Than Waste: Photorespiration Shapes the Plant Epigenome

Mental Health During the Pandemic: NAKO Shows Increased Burden

Sandra Hummel Awarded the Dr. Heinz Bürger-Büsing Prize

Helmholtz Biomedical Engineering Initiative: Shaping the Future of Health

PUREPOLIS: New EU Project for Cleaner, Healthier Cities

NAKO Participates in the National Decade of Post-Infectious Diseases

Eleftheria Zeggini

Stephan Herzig

Martin Hrabě de Angelis

Fabian Theis

Vasilis Ntziachristos

Erika von Mutius

Magdalena Götz

Michael Sattler